1. Home
  2. PLXS vs CRNX Comparison

PLXS vs CRNX Comparison

Compare PLXS & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLXS
  • CRNX
  • Stock Information
  • Founded
  • PLXS 1979
  • CRNX 2008
  • Country
  • PLXS United States
  • CRNX United States
  • Employees
  • PLXS N/A
  • CRNX N/A
  • Industry
  • PLXS Electrical Products
  • CRNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLXS Technology
  • CRNX Health Care
  • Exchange
  • PLXS Nasdaq
  • CRNX Nasdaq
  • Market Cap
  • PLXS N/A
  • CRNX 5.2B
  • IPO Year
  • PLXS 1986
  • CRNX 2018
  • Fundamental
  • Price
  • PLXS $116.13
  • CRNX $28.80
  • Analyst Decision
  • PLXS Buy
  • CRNX Strong Buy
  • Analyst Count
  • PLXS 4
  • CRNX 12
  • Target Price
  • PLXS $164.00
  • CRNX $73.36
  • AVG Volume (30 Days)
  • PLXS 214.0K
  • CRNX 1.1M
  • Earning Date
  • PLXS 04-23-2025
  • CRNX 05-08-2025
  • Dividend Yield
  • PLXS N/A
  • CRNX N/A
  • EPS Growth
  • PLXS N/A
  • CRNX N/A
  • EPS
  • PLXS 4.31
  • CRNX N/A
  • Revenue
  • PLXS $3,954,342,000.00
  • CRNX $1,039,000.00
  • Revenue This Year
  • PLXS $5.18
  • CRNX $356.40
  • Revenue Next Year
  • PLXS $9.41
  • CRNX $845.76
  • P/E Ratio
  • PLXS $26.93
  • CRNX N/A
  • Revenue Growth
  • PLXS N/A
  • CRNX N/A
  • 52 Week Low
  • PLXS $92.72
  • CRNX $28.48
  • 52 Week High
  • PLXS $172.89
  • CRNX $62.53
  • Technical
  • Relative Strength Index (RSI)
  • PLXS 30.98
  • CRNX 29.50
  • Support Level
  • PLXS $125.20
  • CRNX $29.18
  • Resistance Level
  • PLXS $130.30
  • CRNX $35.26
  • Average True Range (ATR)
  • PLXS 3.80
  • CRNX 1.76
  • MACD
  • PLXS 0.04
  • CRNX -0.41
  • Stochastic Oscillator
  • PLXS 6.42
  • CRNX 4.01

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Share on Social Networks: